Webinar | June 7, 2021

Innovation: Shortening The Path To Commercialization In Advanced Therapies

In this panel sponsored by Precision ADVANCE, Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates a discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.

  • Alex Grosvenor SVP, PRECISIONadvisors | Precision Value & Health
  • Dave Lennon President | Novartis Gene Therapies
  • Anshul Mangal President | Project Farma (PF) & Precision ADVANCE
  • Parag V. Meswani Chief Commercial Officer | Sio Gene Therapies
  • Pascal Touchon President & CEO | Atara Biotherapeutics
VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: